Combining AI imaging and spectral chips to create a comprehensive smart medical platform. Yiyang Technology, GLS, Shenguang Chip, and Xiaogang Hospital jointly create a new era of medical testing

【Reporter Ji Xiongshi of Visual Media/Kaohsiung report】

After the epidemic eases, AI will become the next major key factor affecting the medical industry. Thanks to the vigorous development of science and technology, the quality of medical care has been greatly improved, and the average human life expectancy has increased from 40 years in the 19th century to 80 years in the 21st century. Aging has become one of the most important issues in the world and also a serious challenge facing the medical industry. Kaohsiung Xiaogang Hospital will work with Yiyang Technology, Global Life Sciences, and Shenguang Chip to develop a comprehensive medical detection assistance system that combines AI imaging and physiological data, hoping to provide smart medical care, telemedicine, critical care, and long-term care. Bringing global benefits to

In this cooperation project, Xiaogang Hospital is responsible for the development of clinical medical projects and field demonstration, while Yiyang Technology is involved in the hardware and software integration of AI smart medical assistance systems, and Shenguang Chip focuses on the development of spectral chip detection systems and the construction of smart medical big data platforms. The promotion and marketing activities of the company are coordinated by Global Life Sciences.

Director Hung Chih-hsing of Kaohsiung Siao-gang Hospital said: In recent years, Siao-gang Hospital has invested a lot of resources in building a smart hospital. This time, we are able to combine the strength of the industry to build a smart system that combines imaging data and physiological data, and develop targeted An auxiliary system that provides substantial help in clinical practice can not only save resources for doctors to see patients and accelerate the learning of new medical staff, but also provide the public with more convenient and reliable medical services, which can be said to kill two birds with one stone!

Yiyang Technology has long been planning the AI ​​medical market and is a leading manufacturer of medical imaging computing in China. It has also cooperated with international giants such as Intel and NVidia to develop medical AI technology platforms. Its MD116E portable auxiliary system has been used in many domestic and foreign Adopted by benchmark hospitals. Yiyang Global General Manager Zhuang Fujun said: Yiyang has a strong technical background in computers and communications. In recent years, the results of its investment in AI medical care have been deeply recognized by the international market. This cooperation is also an operation to implement diversified growth in AI medical care. strategy, and hopes to develop a more comprehensive medical assistance system by adding the collection of physiological data.

The spectral chip, the result of many years of research by Professor Ke Zhenghao, the founder of Shengguang Chip, will play an important role in collecting physiological data in this cooperation project. The rapid screening and quantitative system developed during the epidemic has demonstrated the strong potential of spectral chips in the medical testing market. Professor Ke Zhenghao further pointed out: Through the series of miniature spectrometers equipped with spectral chips, it is possible to quickly, conveniently and locally obtain test results as accurate as in a laboratory, which will realize the vision of decentralized testing. We hope this collaboration will become an important milestone in the transition from GPU to SPU!

 Wei Muzhong, the GLS spokesperson responsible for global marketing, is very optimistic about the market value of this cooperation. He believes that the global AI smart medical market is estimated to be over 500 billion US dollars. Testing is the beginning of medical treatment. We can accurately grasp the source and then use the computing power of AI to develop auxiliary interpretation models to enable doctors to have more effective medical behaviors. I believe that such a one-stop platform system can really bring global help to telemedicine and precision medicine!

 The signing ceremony of the memorandum of cooperation between the four parties was also attended by Edward, President of the American Chamber of Commerce in Southern Taiwan, and other important figures from home and abroad. They all look forward to the results of this cooperation, which will become a highlight of Taiwan's medical innovation. It can also be promoted to the international market, creating higher market benefits, benefiting the healthy lives of all mankind, and writing another glorious chapter of "Taiwan's experience, benefiting the world."